Welcome to LookChem.com Sign In|Join Free
  • or
2-Chloro-5,8-dimethyl-3-quinolinecarbaldehyde is a chemical compound characterized by the molecular formula C12H10ClNO. It is a yellow solid with a molecular weight of 225.67 g/mol. 2-CHLORO-5,8-DIMETHYL-3-QUINOLINECARBALDEHYDE is known for its role as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly in the production of antimalarial drugs. It also holds potential in the field of medicinal chemistry and is utilized as a reagent in organic synthesis for the development of novel chemical compounds. Due to its potential hazards to human health and the environment, careful handling is advised.

323196-71-0

Post Buying Request

323196-71-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

323196-71-0 Usage

Uses

Used in Pharmaceutical Synthesis:
2-Chloro-5,8-dimethyl-3-quinolinecarbaldehyde is used as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Production:
2-CHLORO-5,8-DIMETHYL-3-QUINOLINECARBALDEHYDE is also utilized in the production of agrochemicals, playing a role in the creation of substances that protect crops and enhance agricultural productivity.
Used in Antimalarial Drug Development:
2-Chloro-5,8-dimethyl-3-quinolinecarbaldehyde is particularly significant in the development of antimalarial drugs, where it serves as a key component in the synthesis of life-saving medications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-CHLORO-5,8-DIMETHYL-3-QUINOLINECARBALDEHYDE is employed for its potential applications in the discovery and design of new chemical entities with therapeutic properties.
Used in Organic Synthesis as a Reagent:
2-Chloro-5,8-dimethyl-3-quinolinecarbaldehyde is used as a reagent in organic synthesis, facilitating the creation of novel chemical compounds for various applications.
Used in Chemical Compound Development:
2-CHLORO-5,8-DIMETHYL-3-QUINOLINECARBALDEHYDE is instrumental in the development of new chemical compounds, expanding the scope of chemical research and innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 323196-71-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,3,1,9 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 323196-71:
(8*3)+(7*2)+(6*3)+(5*1)+(4*9)+(3*6)+(2*7)+(1*1)=130
130 % 10 = 0
So 323196-71-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H10ClNO/c1-7-3-4-8(2)11-10(7)5-9(6-15)12(13)14-11/h3-6H,1-2H3

323196-71-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (BBO000122)  2-Chloro-5,8-dimethylquinoline-3-carboxaldehyde  AldrichCPR

  • 323196-71-0

  • BBO000122-1G

  • 1,930.50CNY

  • Detail

323196-71-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-5,8-dimethylquinoline-3-carbaldehyde

1.2 Other means of identification

Product number -
Other names 2-chloro-5,8-dimethyl-3-quinolinecarbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:323196-71-0 SDS

323196-71-0Relevant academic research and scientific papers

Efficient synthesis of 3-pyrrolylquinolines via an 1,3-dipolar cycloaddition/oxidation sequence

Menasra,Kedjadja,Debache,Rhouati,Belfaitah,Carboni, Bertrand

, p. 2779 - 2788 (2005)

The synthesis of some new functionalized quinolyl derivatives relies on the 1,3-dipolar cycloaddition of an azomethine ylide, generated from sarcosine and paraformaldehyde, to quinolyl α,β-unsaturated esters, followed by oxidation of the pyrrolidinyl moiety to pyrrole with activated MnO2. Copyright Taylor & Francis, Inc.

Ugi efficient synthesis, biological evaluation and molecular docking of coumarin-quinoline hybrids as apoptotic agents through mitochondria-related pathways

Taheri, Salman,Nazifi, Maryam,Mansourian, Mahboubeh,Hosseinzadeh,Shokoohinia

, (2019)

Ugi reaction was a reliable procedure for the synthesis of new coumarin-quinoline frameworks. Excellent yields, mild reaction conditions and easily available and inexpensive starting materials are advantages of this protocol. Cytotoxic effects of fourteen products were investigated in A2780 human ovarian cancer cells. Two synthesized compounds (L11 and L12) exhibited more anti-cancer activity than other derivatives with IC50 values of 0.042 mmol/L and 0.102 mmol/L, respectively and were thus selected for further studies. Apoptosis was induced through the intrinsic pathway by activating caspase 9 and ended at the executioner pathway of caspase 3. Measurement of intracellular reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were also carried out for both of them. Further studies on a mechanism by Real Time-PCR and Western blot analysis were performed for anti-apoptotic proteins Bcl-2 and survivin both in mRNA and protein level relating to the untreated A2780 cells. The treatment of A2780 cells with compound L11 significantly (P-value ≤ 0.05) induced apoptosis by down-regulation of Bcl-2 and survivin both in mRNA and protein level via a single dose (0.042 mmol/L), as well as activation of caspase 9 and 3, loss of MMP, and high ROS. Accordingly, findings supported the first report under which the pro-apoptotic activity of compound L11 as an apoptosis-inducing agent was related to mitochondrial-mediated dysfunction signaling pathways. Molecular docking supports experimental outcomes. Evidently, coumarin-quinoline scaffolds are potentially favorable options for further assessment as influential chemotherapeutic agents for the future.

Synthesis and Herbicidal Activity of Triketone-Quinoline Hybrids as Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors

Wang, Da-Wei,Lin, Hong-Yan,Cao, Run-Jie,Chen, Tao,Wu, Feng-Xu,Hao, Ge-Fei,Chen, Qiong,Yang, Wen-Chao,Yang, Guang-Fu

, p. 5587 - 5596 (2015/06/25)

4-Hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27, HPPD) is one of the most important targets for herbicide discovery. In the search for new HPPD inhibitors with novel scaffolds, triketone-quinoline hybrids were designed and subsequently optimized on the basis of the structure-activity relationship (SAR) studies. Most of the synthesized compounds displayed potent inhibition of Arabidopsis thaliana HPPD (AtHPPD), and some of them exhibited broad-spectrum and promising herbicidal activity at the rate of 150 g ai/ha by postemergence application. Most promisingly, compound III-l, 3-hydroxy-2-(2-methoxy-7-(methylthio)quinoline-3-carbonyl)cyclohex-2-enone (Ki = 0.009 ~M, AtHPPD), had broader spectrum of weed control than mesotrione. Furthermore, compound III-l was much safer to maize at the rate of 150 g ai/ha than mesotrione, demonstrating its great potential as herbicide for weed control in maize fields. Therefore, triketone-quinoline hybrids may serve as new lead structures for novel herbicide discovery.

Synthesis of new 3-(2-Chloroquinolin-3-yl)-5-phenylisoxazole derivatives via click chemistry approach

Ferna?ndez-Galleguillos, Carlos,Saavedra, Luis A.,Gutierrez, Margarita

, p. 365 - 371 (2014/02/14)

Herein, we report the synthesis of new substituted 3-(2-chloroquinolin-3- yl)-5-phenylisoxazole (3a-j) by click chemistry in good to moderate yields. This approach is based on the regioselective copper(I)-catalyzed cycloaddition between different nitrile oxides derived from 2-chloroquinoline- 3-carbaldehyde (2a-j) and phenylacetylene. Finally these derivatives were screened for their antibacterial evaluation in vitro against three Gram-negative clinical bacteria: Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii using standard methods.

Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents

Ramesh, Vadla,Ananda Rao, Boddu,Sharma, Pankaj,Swarna,Thummuri, Dinesh,Srinivas, Kolupula,Naidu,Jayathirtha Rao, Vaidya

, p. 569 - 580 (2014/07/21)

Several rhodanine derivatives (9-39) were synthesized for evaluation of their potential as anticancer agents. Villsmeier cyclization to synthesize aza-aromatic aldehydes, rhodanine derivatives preparation and Knoevenagel type of condensation between the rhodanines and aza-aromatic aldehydes are key steps used for the synthesis of 31 compounds. In vitro antiproliferative activity of the synthesized rhodanine derivatives (9-39) was studied on a panel of six human tumor cell lines viz. HGC, MNK-74, MCF-7, MDAMB-231, DU-145 and PC-3 cell lines. Some of the compounds were capable of inhibiting the proliferation of cancer cell lines at a micromolar concentration. Six compounds are found to be potent against HGC cell lines; compound 15 is found to be active against HGC - Gastric, MCF7 - Breast Cancer and DU145 - Prostate Cancer cell lines; compound 39 is potent against MNK-74; four compounds are found to be potent against MCF-7 cell lines; three compounds are active against MDAMB-231; nine compounds are found to be potent against DU-145; three compounds are active against PC-3 cell lines. These compounds constitute a promising starting point for the development of novel and more potent anticancer agents in future.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 323196-71-0